Cargando…
Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning
[Image: see text] Tomaralimab (OPN-305) is the first humanized immunoglobulin G4 monoclonal antibody against TLR2 and is designed to prevent inflammation that is driven by inappropriate or excessive activation of innate immune pathways. Here, we constructed a homology model of Tomaralimab and its co...
Autores principales: | Ahmad, Bilal, Choi, Sangdun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386714/ https://www.ncbi.nlm.nih.gov/pubmed/35990491 http://dx.doi.org/10.1021/acsomega.2c02559 |
Ejemplares similares
-
Toll-like Receptors from the Perspective of Cancer Treatment
por: Javaid, Nasir, et al.
Publicado: (2020) -
Structure and dynamic behavior of Toll‐like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum
por: Durai, Prasannavenkatesh, et al.
Publicado: (2013) -
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2013) -
Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019) -
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
por: Yesudhas, Dhanusha, et al.
Publicado: (2014)